- Home
- TIL vs DDD Comparison
TIL vs DDD Comparison
Compare TIL & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- DDD
- Stock Information
- Founded
- TIL 2018
- DDD 1986
- Country
- TIL United States
- DDD United States
- Employees
- TIL N/A
- DDD N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- DDD Computer peripheral equipment
- Sector
- TIL Health Care
- DDD Technology
- Exchange
- TIL Nasdaq
- DDD Nasdaq
- Market Cap
- TIL 230.1M
- DDD 231.9M
- IPO Year
- TIL 2021
- DDD N/A
- Fundamental
- Price
- TIL $27.56
- DDD $1.38
- Analyst Decision
- TIL Buy
- DDD Hold
- Analyst Count
- TIL 5
- DDD 3
- Target Price
- TIL $119.00
- DDD $3.50
- AVG Volume (30 Days)
- TIL 503.4K
- DDD 5.6M
- Earning Date
- TIL 08-12-2025
- DDD 05-12-2025
- Dividend Yield
- TIL N/A
- DDD N/A
- EPS Growth
- TIL N/A
- DDD N/A
- EPS
- TIL N/A
- DDD N/A
- Revenue
- TIL N/A
- DDD $431,756,000.00
- Revenue This Year
- TIL N/A
- DDD N/A
- Revenue Next Year
- TIL N/A
- DDD $3.55
- P/E Ratio
- TIL N/A
- DDD N/A
- Revenue Growth
- TIL N/A
- DDD N/A
- 52 Week Low
- TIL $9.62
- DDD $1.33
- 52 Week High
- TIL $92.00
- DDD $5.00
- Technical
- Relative Strength Index (RSI)
- TIL 51.84
- DDD 38.45
- Support Level
- TIL $27.01
- DDD $1.66
- Resistance Level
- TIL $42.79
- DDD $1.98
- Average True Range (ATR)
- TIL 5.01
- DDD 0.12
- MACD
- TIL -1.00
- DDD -0.01
- Stochastic Oscillator
- TIL 9.82
- DDD 1.30
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.